NGF and Miyoshi myopathy: Due to the economic constraints in Brazil, as well as in other Latin American countries (LATAMC), access to new drugs and all standard routine MM diagnostic and follow-up examinations, including serum electrophoresis, immunofixation, free light-chain determinations and NGF or NGS MRD measurements, is still lacking and/or restricted to reference centers [14].